Home » Newsletters » BioWorld Science

BioWorld Science

July 4, 2022

View Archived Issues

FKBP51 blockade ameliorates cognitive function during obesity

New antibacterials described by the Centre National de la Recherche Scientifique (CNRS)

Bayer discovers soluble guanylate cyclase activators

Cancer Research Technology presents new ALDH1A3 inhibitors

LG Chem identifies new proteasome inhibitors

Scripps Research Institute, Vova Ida Therapeutics patent compounds for treating neurodegeneration

CM-1758 shows cytotoxic effects in models of bladder cancer

PXL-065 demonstrates efficacy in preclinical models of ALD

PP2A inhibition sensitizes cancer cells and inhibits their growth

Biomea's menin inhibitor BMF-219 shows prolonged glycemic control in two rat models of diabetes

Noggin expression has prognostic value in pancreatic cancer

First female-specific Alzheimer's risk gene found

Anti-MASP-2 antibody TST-004 shows promise for MASP-2-dependent diseases in vitro and in vivo

Polysaccharide-protein antigen pneumococcal vaccine effective in type 3 invasive disease model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...